Maponos Therapeutics is a cellular therapy company dedicated to development of revolutionary therapeutics for different human diseases, including tissue fibrosis and cancers. We are focused on the cutting-edge technology and discovery of multiple types of cells for innovative and curative treatments.
The company was recently cofounded by three faculty members who are affiliated with the University of Chicago School of Medicine and are among leaders in their respective fields. The company licensed the technologies and know-hows from the University of Chicago. The mission of Maponos Therapeutics is to address the unmet medical need by creating innovative treatment with next-generation cell therapeutics.
Company Details
- Address
- Chicago, 60637, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://maponostherapeutics.com/
- Keywords
- in T cell.
- HQ
- Chicago
Maponos Therapeutics Questions
Maponos Therapeutics's website is https://maponostherapeutics.com/
Maponos Therapeutics's LinkedIn profile is https://www.linkedin.com/company/maponos-therapeutics
Maponos Therapeutics's industry is
Biotechnology Research
Maponos Therapeutics's top competitors are
Progenicyte Therapeutics, Inc.,
Oxalo Therapeutics, Inc.,
Grove Biopharma, Inc.,
Bristol Myers Squibb,
Tract Therapeutics, Inc.,
Maia Biotechnology, Inc.,
Luminary Therapeutics, Inc,
Altathera Pharmaceuticals,
Ctrl Therapeutics,
Dystrogen Therapeutics.
Maponos Therapeutics's categories are Biotechnology Research
